Creative Biolabs conducts general toxicological studies to evaluate the safety assessment in pharmaceutical industries or cancer immunotherapy research. Empowered by our wealth of knowledge, we provide toxicological consulting, toxicological study design and standard conduction, and deal with toxicological issues or unexpected findings during the project process.
General Toxicology Service
Empowered by experienced experts and high-quality in vivo animal models from study design to data analysis, Creative Biolabs offers general toxicology studies in both rodent and non-rodent species in full compliance with Good Laboratory Practice (GLP) regulations. In addition, we provide a wide range of alternative animal models in accordance with your specific general toxicology protocol. We offer the following services, but not limited to:
-
Core Toxicology Services
-
Drug Abuse Liability Solutions
-
Infusion Services
-
Ocular Development Services
-
Nonhuman Primate Studies
-
Juvenile Toxicology Studies
-
Neurotoxicity Study Services
-
Standard for the Exchange of Nonclinical Data (SEND)
Scope of Toxicology Service
-
Small molecule therapeutics such as immune system agonists, antagonists and checkpoint inhibitors;
-
Macromolecular therapeutics including therapeutic cytokines and antibodies;
-
Cellular and gene therapy including adoptive immune cell transfer and oncolytic virus therapeutics;
-
Vaccines.
Highlights
With leading-edge facilities and instruments available, Creative Biolabs holds a comprehensive capability to effectively provide a broad range of general toxicology studies so as to provide superior results for our clients and meet their needs and goals. We guarantee:
-
Quick response with a timely effective report;
-
High quality at an affordable price;
-
Experienced, accessible team of GLP toxicologists;
-
Transforming GLP toxicology results via innovation.
We ensure rapid access to multiple scientific and technological disciplines, which enables Creative Biolabs to be an industry leader in general toxicology services. We are dedicated to getting accurate and reliable data for IND approval within the agreed delivery timeline. Particularly, we offer innovative Ab lock masking services to help global customers improve the selectivity and safety of antibody drugs. Please contact us for a closer communication to
accelerate your therapy development process.